Revolutionizing type 2 diabetes management: the role of the pharmacist in unlocking the potential of tirzepatide.

Saudi Pharm J · 2025 · PMC12712260 · PMID 41405657

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Tirzepatide use was associated with a significant reduction in AMI (RRR: 42%, HR: 0.59; 95% CI: 0.38–0.91; P = 0.016) and all-cause mortality (RRR: 44%, HR: 0.35; 95% CI: 0.14–0.89; P = 0.021), while the reduction in ischemic stroke did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.